Fate Therapeutics Inc

FATE

Add to Watchlist

2.090USD

+0.130+6.63%

Close 06/18, 16:00（ET）Quotes delayed by 15 min

241.10MMarket Cap

LossP/E TTM

Fate Therapeutics Inc

2.090

+0.130+6.63%

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

Overview

Financials

Discussions

Analysis

Company

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

Institutional Confidence

Currency: USD Updated: 2026-06-18

Previous score

7.00

Change

The current institutional shareholding score of Fate Therapeutics Inc is 7.00, ranking 81 out of 389 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 79.47%, representing a quarter-over-quarter decrease of 34.82%. The largest institutional shareholder is Bill Nygren | OAKMX, holding a total of 5.22M shares, representing 8.87% of shares outstanding, with 16.25% increase in holdings.